Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May 18 […]
SEC
Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54 percent of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93 […]
Abbott advises against mini-tender offer
Abbott (NYSE: ABT) appears to be part of the trend of large companies advising their shareholders to avoid unsolicited mini-tender offers. The Abbott Park, Illinois–based maker of diagnostics, medical devices, nutritionals and branded generic medicines posted a news release today in which it advised shareholders to ignore an unsolicited mini-tender offer from TRC Capital Investment […]
SEC lawsuit accuses RenovaCare of securities fraud
The biotech RenovaCare (OTCMKTS: RCAR) announced that it has received a civil complaint from the Securities and Exchange Commission (SEC). The SEC accuses Harmel S. Rayat, a controlling shareholder and chair of RenovaCare, of orchestrating a secret promotional campaign to elevate the company’s stock price. The agency claimed that Rayat and RenovaCare worked with the financial publishing […]